M C Torrado
Overview
Explore the profile of M C Torrado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia Frade L, Sureda A, Torrado M, Garcia Avello A
Acta Haematol
. 1992 Jan;
88(1):7-10.
PMID: 1414164
An exaggerated hemorrhagic syndrome is a characteristic in acute non-lymphoblastic leukemia (ANLL) and it determines the patient's outcome. Disseminated intravascular coagulation as a result of a procoagulant factor release and...
2.
Sureda A, Garcia Frade L, Torrado M, Garcia Larana J, Garcia Avello A
Acta Haematol
. 1992 Jan;
88(2-3):100-4.
PMID: 1281598
A consumption coagulopathy syndrome has frequently been reported in association with some cases of acute nonlymphoblastic leukemia (ANLL) and mainly in acute promyelocytic leukemia (M3). Eighteen cases of ANLL have...
3.
Garcia Frade L, ALVAREZ J, Rayo I, Torrado M, Lasuncion M, Garcia Avello A, et al.
Thromb Res
. 1991 Aug;
63(4):407-18.
PMID: 1836682
Fibrinolysis and lipid disturbances have been considered as independent risk factors for coronary artery disease. Besides this, lipoprotein(a), which is characterized by its homology with plasminogen may interfere with the...
4.
Garcia Avello A, Garcia Frade A, Sureda J, Torrado M
Sangre (Barc)
. 1991 Apr;
36(2):163.
PMID: 1866654
No abstract available.
5.
Garcia Avello A, Garcia Frade L, Ortiz P, Torrado M, Navarro J
Rev Clin Esp
. 1991 Mar;
188(5):227-33.
PMID: 1788455
It is well known that in thrombotic disease the alteration of biological factors such as antithrombin III, protein C, and protein S deficiency, and congenital disfibrinogenimias and displasminogenemias are determining...
6.
Garcia Frade L, de la Calle H, Torrado M, Lara J, Cuellar L, Garcia Avello A
Thromb Res
. 1990 Jul;
59(1):51-9.
PMID: 2119076
The pathogenesis of diabetic vasculopathy has been related to modifications in hemostasis and fibrinolysis. 50 non insulin dependent diabetes mellitus patients have been studied. Euglobulin clot lysis time, fibrin plate,...
7.
Loren M, Garcia Frade L, Torrado M, Navarro J
Thromb Res
. 1989 Oct;
56(1):67-75.
PMID: 2512687
Thrombolytic efficacy is directly related to thrombus age. We used recombinant tissue plasminogen activator (rt-PA), Streptokinase (SK) and Urokinase (UK) on a seven days old inferior vena cava thrombus model....
8.
Garcia Frade L, Torrado M, Loren M, Navarro J
Rev Clin Esp
. 1989 Feb;
184(2):75-9.
PMID: 2502822
"In vitro" efficacy of urokinase (UK), streptokinase (SK) and tissue-type plasminogen activator (t-PA) was studied. Lytic action was measured by dry clot weight, 125I counts released from previously incorporated 125I-fibrinogen...